Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF)

European Neuropsychopharmacology

Volumn 25, Issue 1, 2015, Pages 95-99

  Fuss, Johannes ^a   Hellweg, Rainer ^b   Van Caenegem, Eva ^c   Briken, Peer ^a   Stalla, Günter K ^d   T'Sjoen, Guy ^c   Auer, Matthias K ^d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Estradiol; Gender dysphoria; Gender identity disorder; Neurotrophin; Testosterone; Transgender

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYPROTERONE ACETATE; ESTRADIOL; ESTRADIOL VALERATE; SEX HORMONE; CONTRACEPTIVE AGENT; ESTROGEN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL ARTICLE; FEMALE; HORMONAL THERAPY; HUMAN; MALE; MALE TO FEMALE TRANSGENDER; PROTEIN BLOOD LEVEL; RISK FACTOR; TRANSSEXUALISM; ADOLESCENT; ANALOGS AND DERIVATIVES; ANTHROPOMETRY; BLOOD; FOLLOW UP; MIDDLE AGED; PROCEDURES; PSYCHOLOGICAL RATING SCALE; RETROSPECTIVE STUDY; TRANSGENDER; YOUNG ADULT;

ADOLESCENT; ADULT; ANTHROPOMETRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CONTRACEPTIVE AGENTS; CYPROTERONE ACETATE; ESTRADIOL; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; TRANSGENDERED PERSONS; TRANSSEXUALISM; YOUNG ADULT;

EID: 84920549758     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.11.019     Document Type: Article

References (27)

1. Auer M.K., et al. Twenty years of endocrinologic treatment in transsexualism: analyzing the role of chromosomal analysis and hormonal profiling in the diagnostic work-up. Fertil. Steril. 2013, 100(4):1103-1110l.
2. Auer M.K., et al. Psychopathological profiles in transsexuals and the challenge of their special status among the sexes. PLoS One 2013, 8(10):e78469.
3. Baecke J., Burema J., Frijters J. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am. J. Clin. Nutr. 1982, 36(5):936-942.
4. Begliuomini S., et al. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum. Reprod. 2007, 22(4):995-1002.
5. Bus B., et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011, 36(2):228-239.
6. Chao H.H., et al. Effects of androgen deprivation on cerebral morphometry in prostate cancer patients-an exploratory study. PLoS One 2013, 8(8):e72032.
7. Colizzi M., Costa R., Todarello O. Transsexual patients psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study. Psychoneuroendocrinology 2014, 39(0):65-73.
8. Fontanari A.-M.V., et al. Serum concentrations of brain-derived neurotrophic factor in patients with gender identity disorder. J Psychiatr Res. 2013, 47(10):1546-1548.
9. Fuss J., et al. On the quest for a biomechanism of transsexualism: is there a role for BDNF?. J. Psychiatr. Res. 2013, 47(12):2015-2017.
10. Hellweg R., et al. Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment. Learn. Mem. 2006, 13(1):63-71.
11. Hellweg R., et al. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment. Pharmacopsychiatry 2008, 41(02):66-71.
12. Karege F.l., et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002, 109(2):143-148.
13. Kreukels B., et al. A European network for the investigation of gender incongruence: the ENIGI initiative. Eur. Psychiatry 2012, 27(6):445-450.
14. Li M., et al. Testosterone has sublayer-specific effects on dendritic spine maturation mediated by BDNF and PSD-95 in pyramidal neurons in the hippocampus CA1 area. Brain Res. 2012, 1484(0):76-84.
15. Lommatzsch M., et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging 2005, 26(1):115-123.
16. Miles C., Green R., Hines M. Estrogen treatment effects on cognition, memory and mood in male-to-female transsexuals. Horm. Behav. 2006, 50:708-717.
17. Molendijk M., et al. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations. Mol. Psychiatry 2014, 19(7):791-800.
18. Murad M.M., et al. Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin. Endocrinol. 2010, 72:214-231.
19. Pluchino N., et al. Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause. Hum. Reprod. 2009, 24:2303-2309.
20. Pol H.E.H., et al. Changing your sex changes your brain: influences of testosterone and estrogen on adult human brain structure. Eur. J. Endocrinol. 2006, 155(suppl. 1):S107-S114.
21. Rasmussen P., et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp. Physiol. 2009, 94(10):1062-1069.
22. Rizos E., et al. Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients. Schizophr. Res. 2011, 129(2):201-204.
23. Savic I., Arver S. Sex dimorphism of the brain in male-to-female transsexuals. Cereb. Cortex 2011, 21(11):2525-2533.
24. Schneider H.J., Pickel J., Stalla G.K. Typical female 2nd-4th finger length (2D: 4D) ratios in male-to-female transsexuals-possible implications for prenatal androgen exposure. Psychoneuroendocrinology 2006, 31(2):265-269.
25. Verhovshek T., et al. Androgen regulates brain-derived neurotrophic factor in spinal motoneurons and their target musculature. Endocrinology 2010, 151(1):253-261.
26. Wierckx K., et al. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European Network for the Investigation of Gender Incongruence. J. Sex. Med. 2014, 11(8):1999-2011.
27. Zubiaurre-Elorza L., et al. Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals. J. Sex. Med. 2014, 11(5):1248-1261.